Home News Aurobindo Pharma Q3 Results: Net profit up 8% on Europe, ARV growth... News Aurobindo Pharma Q3 Results: Net profit up 8% on Europe, ARV growth despite labour code cost February 9, 2026 FacebookTwitterPinterestWhatsAppLinkedin Shares of Aurobindo Pharma Ltd ended at ₹1,201.25, up by ₹10.10, or 0.85%, on the BSE.Read More RELATED ARTICLESMORE FROM AUTHOR AI AI startup Emergent scales at record speed by letting anyone build apps on their phone News Digital loans in India remains a massive opportunity despite tighter regulations, says investor Mayank Kachhwaha News IRCON Intl Q3 net profit up 16% on higher margins; revenue dips; dividend declared 13,000FansLike9,000FollowersFollowMost PopularAll AllFeaturedAll time popular UP budget earmarks ₹2,111 Cr for civil aviation; ₹750 crore for... News February 11, 2026 Startup news and updates: Daily roundup (February 11, 2026) Uncategorized February 11, 2026 L&T to Commission 32 MW Data Centre Capacity by March-End, Focuses... Uncategorized February 9, 2026 GoBoult To File IPO Papers By October, Targets Summer 2027 Listing Uncategorized February 10, 2026 When inner peace matters more than seeking approval Uncategorized February 10, 2026